Shahzad Raza

Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial

María‐Victoria Mateos, Hilary Blacklock, Fredrik Schjesvold et al. · The Lancet Haematology · 2019 · 249 citations · Full text

Hematological Malignancy, Oncology, Hematology +6

Antiangiogenic therapy using bevacizumab in recurrent high-grade glioma: impact on local control and patient survival

Ashwatha Narayana, Patrick D. Kelly, John G. Golfinos et al. · Journal of neurosurgery · 2008 · 245 citations

A clinical trial of bevacizumab, temozolomide, and radiation for newly diagnosed glioblastoma

Ashwatha Narayana, Deborah Gruber, Saroj Kunnakkat et al. · Journal of neurosurgery · 2011 · 118 citations

Feasibility of Using Bevacizumab With Radiation Therapy and Temozolomide in Newly Diagnosed High-Grade Glioma

Ashwatha Narayana, John G. Golfinos, Ingeborg Fischer et al. · International Journal of Radiation Oncology*Biology*Physics · 2008 · 90 citations

Neuro-oncology, High-grade Glioma, Radiation Medicine +9

Bevacizumab in recurrent high-grade pediatric gliomas

A. Narayana, Saroj Kunnakkat, Jeena Chacko-Mathew et al. · Neuro-Oncology · 2010 · 80 citations · Full text